Long-acting injectable risperidone in treatment refractory patients: a 14-week open-label pilot study

Schizophr Res. 2010 Nov;123(2-3):273-5. doi: 10.1016/j.schres.2010.07.016. Epub 2010 Aug 4.

Authors

Ric M Procyshyn, Alasdair M Barr, Sean Flynn, Chris Schenk, Soma Ganesan, William G Honer

PMID: 20688481
DOI: 10.1016/j.schres.2010.07.016

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Adult
Antipsychotic Agents / administration & dosage
Antipsychotic Agents / therapeutic use*
Delayed-Action Preparations
Diagnostic and Statistical Manual of Mental Disorders
Dose-Response Relationship, Drug
Female
Humans
Injections, Intramuscular
Male
Middle Aged
Pilot Projects
Psychiatric Status Rating Scales
Psychotic Disorders / diagnosis
Psychotic Disorders / drug therapy*
Psychotic Disorders / psychology*
Recurrence
Risperidone / administration & dosage
Risperidone / therapeutic use*
Schizophrenia / diagnosis
Schizophrenia / drug therapy*
Schizophrenic Psychology*
Treatment Outcome

Substances

Antipsychotic Agents
Delayed-Action Preparations
Risperidone

Associated data

ClinicalTrials.gov/NCT00272597